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It has been shown in previous communications (1-6)  that  the B. 
typhosus  reacting factors of the phenomenon of local skin reactivity 
can be specifically neutralized in multiple proportions by immune sera 
in vitro and in vivo.  If various amounts of a toxic filtrate are titrated 
against a constant amount of immune serum it is possible to determine 
the largest amount of filtrate which is consistently neutralized (i.e. in 
all rabbits tested) by this amount of serum, and thus to express quanti- 
tatively the neutralizing potency of the serum ("CN"  titer).  If the 
titration is continued beyond the CN titer (i.e. in greater quantity of 
toxin) there is usually observed a  rather protracted zone of irregular 
neutralization ("IN" titer) in which the percentage of positive rabbits 
is considerably lower than in the control group.  There is evidently 
present in  these serum-filtrate mixtures a  sufficient amount of non- 
neutralized toxic substance to elicit reactions in rabbits of high suscep- 
tibility to the phenomenon.  If still larger amounts of toxic filtrate 
are titrated one arrives at a point where the addition of serum produces 
no effect.  It is clear that the CN titer,--which indicates how many 
units of toxic filtrate are completely neutralized by a given amount of 
serum,--is  fairly  well  demarcated.  The  results  obtained  by  the 
determination  of  the  IN  titer  (i.e.  of  the  largest  number  of units 
irregularly neutralized by a given amount of serum) are less accurate 
because  of  the  individual  fluctuations  in  susceptibility  of  normal 
rabbits to the phenomenon. 
When considerable data had been accumulated concerning the neu- 
tralization  of B.  typhosus  toxic  substances  and  the phenomenon  of 
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local skin reactivity had been also successfully produced with meningo- 
coccus culture filtrates (7), an attempt was made to study the neutraliz- 
ing  potency of  antimeningococcus horse  sera  in  order  to  obtain  a 
laboratory method for the evaluation of the curative effect of these 
sera.  It became evident from these studies, however, that among the 
various batches of therapeutic sera tested, none was sufficiently power- 
ful to produce consistent neutralization similar to that obtained in the 
work on B. typhosus.  It was then decided to compute the potency by 
the determination of the IN titer.  This was done by finding the high- 
est dilution of a serum capable of inhibiting reactions in at least three 
out of five rabbits injected with doses which elicited reactions in about 
75 per cent of control rabbits (8).  At the same time the immunization 
of horses was begun in an effort to develop a serum of higher neutraliz- 
ing potency.  The immunization consisted of subcutaneous injections 
of toxic filtrates and intravenous injections of heat-killed and live cul- 
tures.  With  considerable  difficulties,  sometimes  shortly  after  the 
beginning of immunization,  sometimes after  many months,  it  was 
occasionally possible to obtain a serum which neutralized consistently 
a fairly large number of toxic units.  In these determinations there was 
again  adopted the above  described titration  of various  amounts of 
toxic  units  against  constant  amounts  of  serum  (i.e.  0.25  cc.)  (9). 
However, further studies brought out the curious fact that in certain 
sera of a  low CN titer the IN titer appeared quite high.  Moreover, 
if multiples of 0.25  cc. were tested, the CN titer did not increase pro- 
portionately, a fact illustrated by the following example: 
0.25 cc. of antimeningococcus  horse serum H7 Bl~0 showed complete neutraliza- 
tion of 15 toxic units and irregular neutralization of 40 units.  1 cc. of the same 
serum showed  irregular neutralization of 25 units. 
This is in striking contrast to observations made with other immune 
sera (i.e. antityphoid and anticoli horse sera), which showed complete 
neutralization in multiple proportions.  It seemed possible  that the 
inability of antimeningococcus sera to neutralize completely the toxic 
factors in multiple proportions may  be due to the lack of some auxiliary 
factor, perhaps non-specific in nature.  A  search was made for this 
hypothetical auxiliary factor.  This was done by studying the neutrali- 
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antimeningococcus sera with heterologous immune sera which by them- 
selves were capable of complete neutralization in multiple proportions 
of their homologous toxic substances.  The results of the work are 
embodied in this paper. 
EXPERIMENTAL 
Tables I and II present a summary of experiments on neutralization 
of the reacting factors of various serological groups of meningococcus by 
means of polyvalent antirneningococcus horse sera and also by means 
of mixtures of these sera with various normal and heterologous immune 
sera. 
On the morning of the experiment the serum mixtures were made in proportions 
indicated in the tables.  These  were kept for from 1 to 2 hours at room tempera- 
ture.  The technique of neutralization experiments was the same as described 
before (9), except that each test was done on three instead of four rabbits.  If no 
reactions were obtained in the three rabbits tested, the result was considered as 
showing consistent neutralization of reacting factors (CN).  If one of three rabbits 
showed a reaction the result was recorded as "irregular neutralization" (IN).  If 
two of three or all rabbits showed  reactions there was recorded "no neutralization" 
("NN"). 
As is seen from Table I, antimeningococcus  horse sera tested in various 
amounts against filtrates of two strains of Group I, of one non-grouped 
patient's strain  ("Fabio"), and  of one  Group  III  strain gave  only 
irregular neutralizations.  The larger the amount of serum used, the 
higher was the IN titer.  Mixtures of the various heterologous sera 
indicated in the table and also of two batches of normal horse serawith 
the same  antimeningocococcus sera  also  showed only irregular neu- 
tralizations. 
As is seen in Table II, mixtures of antimeningococcus horse sera with 
anticoli  horse  serum  displayed  a  remarkable  neutralizing potency. 
First, these mixtures exhibited a  substantial increase in the  IN titer 
(see Table I, Groups 2 and 11 and Table II, Groups 2 and 16);  second, 
they showed complete neutralization of large numbers of toxic units; 
and, third, they differed in their potency for filtrates of various sero- 
logical groups (Table II, Groups 8, 9, 10, and 27). 
As illustrated by Groups  1 to  10  of Table II, it  was  possible  to 
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TABLE  I 
Neutralization of Meningococcus  Reacting Factors by Means of Mixtures of Normal 
and Heterologous Sera with Antimeningococcus Sera 
Rabbit 
group 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
Antimen-  [ 
Ingoc0ccus  ] 
horse serur 
H7 Bliss 
g~  g~ 
H~ Bl~s7 
H~ Bl~o 
H~ Bl~s~ 
((  (( 
H7 Blno 
H7 Bl~ss 
H7 Bl~0 
~mou 
~er kl 
weigl 
co. 
0.3; 
0.4 
1 
1 
0.3~ 
0.& 
1 
1 
1 
1 
O.2, 
1 
1 
0.4 
0.2 
0.9 
0.4 
0.9 
0.4 
0.4 
0.4 
0.4 
0.5 
0.9 
0.9 
0.9 
Heterologous and normal 
horse sera 
1 
m 
m 
Normal horse  serum 
176/177 
Normal horse serum 
213 
Scarlet  fever  anti- 
toxin 
Antityphoid  horse 
serum 16/194 
Tetanus  antitoxin 
N.Y.B.H. 
Type I pueumococ- 
cus  antibody 
N.Y.B.H. 
Antityphoid  horse 
Serum 16/194 
Human convalescent 
pneumonia serum 
Antityphoid  horse 
Serum 16/194 
Type  II  pneumo- 
coccus  antibody 
N.Y.B.H. 
moun 
er kill  Meningococcus strain 
veighl  used for toxic filtrate 
--  Group I  (44 D) 
--  Group I  (123) 
--  "Fabio" 
--  Group III (44 B) 
--  Group I (44  D) 
0.6  "  " 
0.8  "  " 
0.1  "  " 
0.6  Group III (44 B) 
0.8  "  " 
0.6  Group I  (44 D) 
0.6  "  " 
0.6  "  " 
0.6  "  " 
0.5  "  " 
0.1  Group III (44 B) 
0.1  "  " 
O. 1  "  " 
~'0. of 
toxic  Results 
units 
100  N  N 
100  " 
100  I N 
125  " 
40  NN 
60  " 
50  " 
75  " 
100  " 
90  I N 
25  " 
40  ]  " 
50  N  N 
100  " 
100  " 
100  " 
60  " 
S0  I  N 
100  N  N 
100  " 
100  " 
100  " 
100  " 
100  " 
100 l  " 
100  " TABLE  II 
Neutralization  of  Meningococcus  Reacting  Factors  by  Means  of  Mixtures  of  A  nticoli 
Horse  Serum  with  Antimeningococcus  Horse  Sera 
Rab- 
bit  Antimen-  Amount  AnticoU  Amount per kilo 
:roup  ingococcus  per kilo 
No.  horse serum  weight  horse serum  weight 
CC.  CC, 
1  H~ Bliss  0.4  H6o  Bliss  0.6 
2  "  "  0.4  "  "  0.6 
3  "  "  0.4  "  "  0.6 
4  H7 Bl~s~  0.9  "  "  0.1 
5  "  "  0.9  "  "  0.1 
6  H7 Blls,  0.9  "  "  0.1 
7  "  "  0.9  "  "  0.1 
8  H~ Bl~o  0.4  "  "  0.6 
9  "  "  0.4  "  "  0.6 
10  "  "  0.4  "  "  0.6 
11  --  --  "  "  0.1 
12  --  --  "  "  0.l 
13  --  --  "  "  0.5 
14  --  --  "  "  0.5 
15  --  --  "  "  1 
16  --  --  "  "  1 
17  --  "  "  O. 1 
18  --  "  "  0.1 
19  ....  "  0.5 
20  --  --  "  "  0.5 
21  --  --  "  "  1 
22  --  --  "  "  1 
23  Hs Blm  0.9  "  "  O. 1 
24  "  "  0.9  "  "  0.1 
25  "  "  0.9  "  "  0.5 
26  "  "  0.9  "  "  0.5 
27  Hr Bl**o  0.4  "  "  0.6 
28  H7 BI~  0.3 
29  "  "  0.3 
30  "  "  0.3  --  I  -- 
B 
i 
31  "  "  0.6  -- 
32  "  "  0.6  -- 
33  "  "  0.9  -- 
34  "  "  0.9 
35  "  "  1 
36  "  "  0.3  I-ho Bliss  0.1 
37  "  "  0.3  "  "  0.1 
38  "  "  0.6  "  "  0.1 
39  "  "  0.6  "  "  0.1 
40  "  "  0.9  "  "  0.1 
4i  ....  0.9  "  "  0.1 
42  "  "  0.9  "  "  0.1 
43  "  "  0.9  "  "  0.1 
Dilution  1:3 
44  "  "  0.9  "  "  0.1cc. 
Dilution  1:3 
No. of 
Meningococcus strain  toxic  Results 
used for toxic filtrate  units 
Group I  (44 D)  100  C  N 
"  "  130  I  N 
"  "  160  N  N 
Group I  (123)  100  C  N 
"  "  130  N  N 
"Fabio"  100  C  N 
"  130  N  N 
Group III  (44 B)  60  C  N 
"  "  100  " 
"  "  125  I  N 
Group I  (44 D)  8  C  N 
"  "  20  N  N 
"  "  30  C  N 
"  "  60  N  N 
"  "  90  C  N 
"  "  110  I  N 
Group III  (44 B)  15  C  N 
"  "  25  N  N 
"  "  45  C  N 
"  "  60  N  N 
"  "  90  C  N 
"  "  110  I  N 
"  "  110  C  N 
"  "  140  N  N 
"  "  II0  C  N 
"  "  140  N  N 
Group I  (44 D)  50  " 
Group III  (44 B)  6  C  N 
"  "  15  I  N 
"  "  25  N  N 
"  "  10  C  N 
"  "  25  N  N 
"  "  20  I  N 
"  "  36  " 
"  "  50  N  N 
"  "  8  I  N 
"  "  18  N  N 
"  "  12  C  N 
"  "  20  N  N 
"  "'  25  C  N 
"  "  30  " 
"  "  40  I  N 
"  "  18  " 
"  "  25  N  N 
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neutralizes completely 100 toxic units and only irregularly 130 units, 
the CN titer is approximately 115 units.  The CN determinations, as 
mentioned above, are considerably more accurate than  the IN titra- 
tions. 
Table II also includes data on the reciprocal relationships between 
the anticoli and antimeningococcus horse sera. 
As is seen from Groups 11 to 22, the anticoli horse serum was by itself 
capable of giving complete neutralization of meningococcus reacting 
factors.  The neutralizing proPertY of this  serum,  however,  differed 
in  several  respects  from  the  specific antibody of antimeningococcus 
serum:--It  had  no  agglutinins  and  precipitins  for  meningococcus 
(unrecorded  experiments);  it  neutralized  the  toxic  factors  of  both 
serological Groups I  and III to the same degree; and it was  capable of 
complete neutralization in multiple proportions. 
The next step was to determine whether the high complete neutral- 
ization obtained with the mixtures described was due to summation of 
neutralizing titers of sera making up the mixtures. 
Inasmuch as 0.1 and 0.5 cc. of anticoli horse Serum Hs0 Bliss contain about 15 
and 45 CN units, respectively, it follows that, should there be summation of titers, 
then a mixture consisting of 0.9 cc. of antimeningococcus Serum Hs B1251 and 0.5 cc. 
of Serum Hs0 Bliss must have a higher titer than a mixture consisting of the same 
amount of the antimeningococcus serum and only 0.1 cc. of Serum H60 Bliss.  How- 
ever, as is seen from Groups 23 to 26, both mixtures remained of the same titer. 
Similarly, in case of summation of titers, any mixture containing 0.6 cc. of anticoli 
horse Serum H60 Bliss should have at least 50 neutralizing units irrespective of the 
titer of the antimeningococcus  serum.  But, as is seen from Groups 1 to 3 and 27, 
a mixture consisting of 0.4 cc. of antimeningococcus  Serum H7 Blls9 and 0.6 cc. of 
anticoli horse Serum He0 Bl188 gave a CN titer of 115 units, while a mixture consist- 
ing of 0.4 cc. of antimeningococcus Serum H7 Bl~20 and 0.6 cc. of the same anticoli 
serum gave no neutralization of 50 units.  As is seen from Groups 3 and 4 of Table 
I  and Group 35 of Table II,  the antimeningococcus  Serum H7 Blls9 had a higher 
IN titer than Serum H7 B1220. 
From the data thus far presented,  therefore, the following  conclu- 
sions can be drawn: 
1.  The high CN titer of mixtures of antimeningococcus and  anticoli 
sera is not due to mere summation of titers of both sera. 
2.  The addition  of anticoli serum to antimeningococcus serum of a 
low neutralizing potency does not bring about any increase in potency GREGORY  SHWARTZMAN  717 
of the  mixture.  Moreover,  the  independent  neutralizing potency of 
the anticoli serum seems t'o become abolished altogether when mixed 
with an aritimeningococcus serum poor in neutralizing antibodies. 
3.  The addition of anticoli serum to an antimeningococcus serum of 
a high IN titer results in a high CN titer of the mixture. 
These  conclusions  can  be  further  supported  by  experiments  with 
Groups 28 to 44 of Table II. 
In  these  experiments  there  was  tested  the  neutralizing  potency  of various 
amounts of antimeningococcus Serum H7 B1202 and of mixtures of this serum with 
diluted  and undiluted  anticoli horse  Serum H60 B1188.  As could be  expected, 
various amounts of antimeningococcus serum alone gave irregular neutralizations 
except when tested with small numbers of toxic units.  The addition of 0.1 cc. of 
anticoli serum previously diluted 1 : 3 had no effect on neutralizing potency.  Mix- 
tures of amounts as small as 0.3 and 0.6 cc. of antimeningococcus serum with 0.1 cc. 
of undiluted anticoli serum did not result in any noticeable increase of the CN titer. 
In spite of the fact that the latter amount of anticoli serum could neutralize com- 
pletely about 15 toxic units and 0.3 and 0.6 cc. of antimeningococcus serum could 
neutralize completely 10 and 15 units, respectively, the mixture of 0.3 cc. of anti- 
meningococcus serum with 0.1  cc. of undiluted  anticoli serum neutralized com- 
pletely less than 8 units, and the mixture of 0.6 cc. of antimeningococcus serum with 
the above amount of anticoli serum neutralized completely only 15 units, i.e.  the 
same number  of units which could be neutralized independently by either ingredient 
of the mixture.  However, when 0.1 cc. of undiluted anticoli serum was added to 
0.9 cc. of antimeningococcus serum, the mixture gave complete neutralization of 35 
toxic units, although this amount of antimeningococcus serum gave independently 
only irregular neutralization of 20 units. 
From these observations it is seen again that the anticoli serum does 
not  exhibit  its  independent  neutralizing  potency  when  mixed  with 
antimeningococcus  serum  containing  neutralizing  antibodies  of  low 
concentration (0.3 cc. of HTB120~) ; that it produces no effect when added 
to  a  somewhat  larger  amount  of  antimeningococcus  antibodies  (i.e. 
0.6  cc. of H7 Bl~02); and that it converts (beyond its own neutralizing 
potency)  irregular  neutralization  into  complete  neutralization  when 
added  to  a  sufficient  concentration  of  antimeningococcus  antibodies 
capable  of  irregular  neutralization.  For  these  reasons  it  may  be 
assumed that  the  anticoli serum contributes  some auxiliary factor to 
the specific antibody +  antigen combination and enters with it into an 
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Further studies were made in order to define closer the nature of the 
auxiliary factor in the anticoli horse serum. 
The following horse sera were tested for complement and anticom- 
plementary  properties,  namely:  anticoli  Serum  H60Bllss;  normal 
Serum 176/177; antimeningococcus Sera HTB118~, HTB1189, and HTBl~02. 
Amounts of each serum tested for complement  were 0.01, 0.05, 0.1, and 0.2 cc. 
These amounts were each mixed with 2 units of sheep red blood cell "amboceptor" 
(i.e. 0.1 cc. of 1:50 dilution) and 0.5 cc. of 5 per cent suspension of sheep red blood 
cells.  The mixtures  were incubated in a water bath at 37 ° for 30 minutes  No 
hemolysis occurred in any of the tubes. 
The  same  sera  in  above mentioned amounts were  tested  for anti- 
complementary property in two ways: 
Test/.--The various amounts of sera  were each mixed with  1 unit of guinea 
pig complement.  After incubation  in water bath at 37  ° for 30 minutes there was 
added to each of the mixtures 0.5 cc. of a 5 per cent suspension of sheep red blood 
cells and 2 units of sheep red blood cell "ambocepter."  The new mixtures  were 
then  incubated in water  bath at 37  ° for 20 minutes.  All  the sera proved to be 
anticomplementaryin 0.I and 0.2 cc. amounts.  Sera  176/177 and H60 Blls9 were 
slightly less anticomplementary than the others. 
Test//.--In this test the various amounts of sera were mixed each with 1 unit 
of guinea pig complement and 0.2 cc. of beef heart antigen used for Wassermann 
tests.  The rest of the technique and the results were the same as in Test I. 
Heating of the sera at 56  ° for 30 minutes  completely removed the anticomple- 
mentary property. 
These experiments established  the  fact that  the auxiliary factor is 
not in the nature of complement and has no apparent relation  to the 
anticomplementary property of sera. 
In Table III there are  summarized tests for the auxiliary factor in 
various bleedings of several horses immunized with B. coli cultures and 
culture filtrates.  These tests were carried out in the manner described 
on page 713. 
The sera tested were added to a given antimeningococcus serum in the propor- 
tion  1:10.  Two antimeningococcus  sera,  H~ BI2o~ and H7 B1220, were employed 
alternately.  The amounts of Group III toxic filtrate  used were 35 and 90 units 
respectively,  completely neutralized  by mixtures  of these sera with anticoli horse 
serum H60 Bl188.1  (See  Table II.) 
1The CN titer of 9 parts of Hr B120~ -I-  1 part H0o Bliss was 35 units.  The CN 
titer of mixture of 9 parts of Hr B12.oo -I- 1 part H~o B118s exceeded 90 units. GREGORY  SHWARTZMAN  719 
The horses were immunized as follows: 
Horse 20.--Immunization began 7/26/29.  The first dose was a subcutaneous 
injection of 10 cc. of "B. coll polyvalent toxin."  The latter consisted of a mixture 
of filtrates  of 5 day old tryptic digest  broth cultures  of fourteen  strains.  Two 
strains  were rough.  The remaining  strains  were  smooth.  0.2  cc.  of potassium 
alum was added to the filtrate  before  injection.  All the injections  were made at 
weekly intervals.  The first 2 months the horse received only subcutaneous  !njec 
tions.  The doses were gradually increased so that on 9/26/29 there was injected 
subcutaneously 200 cc. of the filtrate.  From this date the horse was immunized 
weekly both subcutaneously with the filtrate  and also intravenously with "poly- 
valent heat-killed  B. coli vaccine."  The latter consisted of a mixture of the same 
strains  employed for preparation of the filtrates.  The first intravenous dose was 
100,000,000 organisms.  There was also a gradual increase with each subsequent 
injection.  On  11/26/29 the intravenous dose of one-half  billion organisms  was 
reached.  The subcutaneous  doses fluctuated from 150 to 200 cc. during the period 
between  9/26 and 11/26/31.  Bleeding 95 was made 11/25/31.  The immuniza- 
tion was continued in a similar manner until May, 1930, the subcutaneous  doses 
fluctuating between  150 and 200 cc. and the intravenous doses between  one-half 
billion and one billion organisms.  Horses 60, 2, 8, and 148 were immunized for 
various periods  of time in a manner similar  to Horse 20.  During the course of 
immunization  Horse 60 rested  a few times, for several weeks each  time----as indi- 
cated in Table III. 
Horse 101.--Immunization  of this horse was less intensive.  It began 9/29/31 
and continued at weekly intervals.  The first subcutaneous  dose was 5 cc. of the 
"polyvalent B. coli toxin."  The subcutaneous  doses were gradually increased so 
that 4/2/31 the horse received 20 cc. of the filtrate.  From 4/9 to 5/9/31 the horse 
received both subcutaneous injections of the "polyvalent B. coli toxin" and intra- 
venous injections  of the  "polyvalent heat-killed  B.  coli  vaccine."  Thesubcu- 
taneous  dose  of 85  cc.  was  reached  on  5/9/31.  The intravenous  doses  were 
also  gradually increased  with  each  injection.  The  first  intravenous  dose  was 
300,000,000 organisms.  On 5/9/31 the horse received intravenously 800,000,000 
organisms. 
As is  seen  from Table  III, the  auxiliary factor described is  in  the 
nature  of  an  antibody,  the  production  of  which  is  stimulated  by 
immunization with B. coli heated cultures and culture filtrates. 
The antibody appears shortly after the beginning of immunization. 
The length of time necessary, however, for its development differs in 
horses under the same treatment.  Thus, after 10 weeks of immuniza- 
tion the antibody was absent in Horse 2, but already present in Horse 
8.  The majority of horses developed the antibody in 8  to  10 weeks. 
The antibody also disappeared in Horses 20 and 60 during the process 720  LOCAL  SKIN  REACTIVITY  TO  BACTERIAL  :FILTRATES 
TABLE  III 
Auxiliary Factor in Horses Immunized with B. coli Cultures  and Culture  Filtrates 
No. of men-  No. of days  ingococcus  Antimeningo-  Bleedings of 
Group III  cOccus horse  anticoli  No. of weeks of immunization  after last in- 
toxic units  serum  horses  and rest  jection bleed-  Result 
ing obtained 
90 
90 
90 
90 
90 
35 
90 
90 
90 
35 
35 
35 
90 
90 
90 
90 
90 
35 
35 
35 
35 
35 
35 
35 
H~ Bl~o 
H7 BI2o2 
H7 B122o 
H7 Bl,o, 
H7 Bl~o 
c~  g¢ 
H7 B12o~ 
H2o BI.~ 
H2o  Bln6 
H2o Bll,s 
Heo Bll.9 
H6o Bliss 
Hso B12o~ 
H7 Bl,o. 
H6o BI217 
Hso B12so 
H6o Bl2so 
H6o B12ee 
H6o B12so 
Hl4s B197 
I-I~o Bls5 
H,~o Blm 
H. B12o5 
Hs B12o~ 
HlOl B1242 
Hlol B1257 
Hm Bl~2 
Hm Bl~7 
Hlot Bl~7 
Hlot BI2~ 
H1ot B12o8 
17, immuniz. 
31,  " 
44,  ~ 
12,  " 
3, rest 
19, immuniz., 
3, rest 
24, lmmunlz., 
3, rest 
26, lmmumz., 
3, rest 
28, lmmunlz., 
3, rest 
31, lmmurllz., 
3, rest 
33, lmmumz., 
8, rest 
33, lmmumz., 
9, rest 
36, lmmunlz., 
9, rest 
12, lmmumz. 
6,  " 
26,  " 
10,  " 
10,  " 
Bleeding before immuniz. 
3, immuniz. 
4,  " 
5~  ¢¢ 
7,  ¢~ 
8~  ~¢ 
9~  ~¢ 
6 
6 
6 
21 
21 
28 
Jc** 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
*  -- No auxiliary factor, since only irregular or no neutralization obtained. 
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of immunization.  After the disappearance of the antibody, Horse 60 
was  rested  intermittently for  9  weeks.  3  weeks  of  immunization 
following the last period of 3 weeks rest again stimulated the produc- 
tion of the ~ntibody. 
The question of what happens to the anticoli antibody simultane- 
ously with these fluctuations in auxiliary antibody will be taken up 
subsequently. 
DISCUSSION AND  CONCLUSIONS 
The present paper  embodies data  concerning a  certain  antibody 
auxiliary to neutralization of meningococcus reacting factors. 
The  auxiliary  antibody is  not complement and has  no  apparent 
relationship to the anticomplementary  property of horse sera. 
The antibody is produced by immunization of horses with B.  coli 
heat-killed cultures and culture filtrates.  It appears shortly after the 
beginning of immunization and it may disappear during the process of 
immunization.  Horses in which the antibody disappears can regain 
their power of producing it after a few weeks of immunization, follow- 
ing a period of rest. 
The auxiliary antibody is absent from other heterologous and normal 
horse sera thus far tested. 
When the auxiliary antibody is mixed in vitro with an antimeningo- 
coccus horse serum which by itself is capable of irregular neutralization 
in a high titer the effect is as follows: 
The IN titer of the mixture is increased; the mixture acquires the 
power of complete neutralization (CN titer) of large numbers of toxic 
units; it differs in its potency for filtrates of various serological groups. 
However, the auxiliary antibody does not exhibit its effect in mix- 
tures with antimeningococcus sera unless the latter contain neutraliz- 
ing antibodies of sufficient potency and concentration. 
The employment of the auxiliary antibody enables one to express the 
neutralizing value  of  antimeningococcus sera  in  terms  of  complete 
neutralization and fhus gives an accurate method for their comparative 
evaluation. 
It has been shown in previous communications that the potency of 
toxic filtrates fluctuates in storage.  This considerably handicaps the 722  LOCAL  SKIN  REACTIVITY  TO  BACTERIAL  FILTRATES 
studies  on  neutralizing  antibodies  of sere.  Inasmuch  as  in  recent 
observations the CN titer of mixtures of antimeningococcus sere with 
the auxiliary antibody appeared to be quite stable, * an opportunity 
presents  itself to  titrate  the potency of filtrates  against  a  "stock" 
standard serum and thus determine the toxic titer of filtrates more 
accurately than by direct titrations. 
It  remains to be seen whether the reinforcement of antimeningo- 
coccus horse sere by means of the auxiliary antibody increases their 
therapeutic value. 
This paper also includes data on a  non-specific neutralizing factor 
of the following characteristics: 
1.  It is present in a heterologous immune serum (i.e.  anticoli horse 
serum). 
2.  It  is not associated with specific antimeningococcus antibodies 
(i. e.  agglutinins and precipitins). 
3.  It apparently displays no serological group specificity. 
4.  It gives complete neutralization of meningococcus reacting factors 
in multiple proportions. 
5.  Its neutralizing effect is not displayed when mixed with an anti- 
meningococcus serum of low potency. 
6.  It is not complement and not associated with anticomplementary 
properties of horse sere. 
These properties have to be differentiated from those of the specific 
neutralizing antibodies of antimeningococcus sere (8, 9).  The latter 
are stimulated by immunization with meningococcus antigens;  they 
exhibit  species,  serological group,  and  variant  specificity; they are 
obtained in high potency with considerable difficulties; and in  most 
instances they neutralize completely only small numbers of toxic units, 
but are capable of incomplete neutralization of considerable amounts of 
toxic filtrates.  When multiples of a  given amount of  antimeningo- 
coccus serum are tested there is a proportionate increase in the titer of 
irregular neutralization but no proportionate increase in the CN titer. 
Work  is  in  progress  to  determine the  nature  of  the  non-specific 
neutralizing factor and also to establish its relations to the auxiliary 
antibody. 
2  The mixtures were always made the day of the experiment. GREGORY SHWARTZMAN  723 
SUMMARY 
In this paper there is described an antibody auxiliary to the neutrali- 
zation of meningococcus reacting factors.  The presence of the anti- 
body facilitates studies on neutralizing potency of antimeningococcus 
sera. 
There is also reported a non-specific neutralizing factor of a heterolo- 
gous immune serum, which can be differentiated from specific neutral- 
izing antibodies of antimeningococcus sera.  Its nature and connection 
with the auxiliary antibody remain to bedetermined. 
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